Weight Loss
Compounded GLP-1 medications prescribed by a licensed provider when clinically appropriate. Monthly subscription — all medication, all provider visits, and shipping included, with titration support built into the program.
Who this program is for
Prescription weight management with compounded GLP-1 medications is prescribed based on your provider's clinical judgment following a health assessment.
Generally, providers consider adults with a BMI in the range typically associated with obesity, or overweight combined with a weight-related medical condition, who have tried lifestyle changes without sustained results. Eligibility is reviewed as part of your intake — not everyone who inquires will be a fit.
Important safety information
Do not use if you or a family member have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are pregnant, planning pregnancy, or breastfeeding.
Additional contraindications and side effects are reviewed as part of intake and detailed on each product page. Full safety information required before starting treatment.
Weight management program details coming soon.
HerTeleMeds is a cash-pay telehealth program. Compounded medications referenced above contain the same active ingredient as certain FDA-approved brand-name products but the compounded formulations themselves are not FDA-approved. Prescribing follows the licensed provider's independent clinical judgment based on your health assessment.
Prescription required. Available only to patients who meet clinical eligibility criteria. Not available in all states. Individual results vary; weight management outcomes require combination with reduced-calorie eating and increased physical activity.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. HerTeleMeds is not affiliated with, endorsed by, or associated with Novo Nordisk A/S or Eli Lilly and Company. Any brand-name references are for factual comparison of active ingredient only.